PGEN · NASDAQ
Precigen (PGEN) Stock Price & Fundamentals
Precigen (PGEN) closed at $953.67 on Oct 9, 2026, up 0.14% from the previous close of $952.31.
Share price, past year
1Y −20.07%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $953.67 |
| Sep 30, 2026 | $984.22 |
| Aug 31, 2026 | $954.35 |
| Jul 31, 2026 | $967.66 |
| Jun 30, 2026 | $1,029.38 |
| May 29, 2026 | $999.61 |
| Apr 30, 2026 | $1,015.60 |
| Mar 31, 2026 | $1,050.39 |
| Feb 27, 2026 | $1,082.69 |
| Jan 30, 2026 | $1,119.35 |
| Dec 31, 2025 | $1,176.34 |
| Nov 28, 2025 | $1,120.85 |
| Oct 31, 2025 | $1,167.41 |
Key statistics
- Market cap
- $341.42B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.07
- Revenue (TTM)
- —
- Net income (TTM)
- −$157.71M
- Shares outstanding
- 358M
- Dividend yield
- —
- 52-week range
- $939.91 – $1,193.15
Precigen's market cap is $341.42B, based on a share price of $953.67 and 358M shares outstanding as of Jun 30, 2026.
Financials
Precigen reported revenue of $9.68M for fiscal 2025, up 146.73% from fiscal 2024.
Precigen reported a net loss of $250.64M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $9.68M | +146.7% | −$250.64M | −2,588.2% | −$1.37 | −$89.83M |
| FY2024ended Dec 31, 2024 | $3.93M | −37.0% | −$126.24M | −3,216.2% | −$0.47 | −$76.76M |
| FY2023ended Dec 31, 2023 | $6.23M | −76.9% | −$95.90M | −1,540.6% | −$0.39 | −$68.47M |
| FY2022ended Dec 31, 2022 | $26.91M | +88.6% | $28.32M | 105.2% | $0.14 | −$69.97M |
| FY2021ended Dec 31, 2021 | $14.27M | −55.4% | −$92.17M | −646.0% | −$0.47 | −$63.02M |
| FY2020ended Dec 31, 2020 | $31.99M | −64.7% | −$170.52M | −533.0% | −$1.02 | −$84.55M |
| FY2019ended Dec 31, 2019 | $90.72M | −40.0% | −$322.32M | −355.3% | −$2.09 | −$173.81M |
| FY2018ended Dec 31, 2018 | $151.18M | −34.6% | −$509.34M | −336.9% | −$3.93 | −$165.83M |
| FY2017ended Dec 31, 2017 | $230.98M | +21.0% | −$117.02M | −50.7% | −$0.98 | −$150.39M |
| FY2016ended Dec 31, 2016 | $190.93M | — | −$186.61M | −97.7% | −$1.58 | −$80.62M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $54.98M | $20.07M | $0.05 |
| Q1 FY2026ended Mar 31, 2026 | $23.25M | −$7.93M | −$0.02 |
| Q2 FY2025ended Jun 30, 2025 | $856.00K | −$26.64M | −$0.09 |
| Q1 FY2025ended Mar 31, 2025 | $1.34M | −$54.15M | −$0.18 |
| Q2 FY2023ended Jun 30, 2023 | $1.77M | — | — |
| Q1 FY2023ended Mar 31, 2023 | $1.85M | — | — |
| Q4 FY2022ended Dec 31, 2022 | $1.76M | — | — |
| Q3 FY2022ended Sep 30, 2022 | $16.72M | — | — |
Company profile
- Name
- Precigen, Inc.
- Ticker
- PGEN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 20374 Seneca Meadows Parkway, Germantown, MD 20876
- Incorporated in
- VA
- Fiscal year ends
- December
- SEC CIK
- 0001356090
Recent SEC filings
- Aug 4, 2026
- Aug 4, 2026
- Jun 24, 2026
- May 13, 2026
- May 13, 2026
- Mar 25, 2026
- Mar 25, 2026
- Nov 13, 2025
Frequently asked questions
What is Precigen's stock price?
Precigen (PGEN) closed at $953.67 on Oct 9, 2026, up 0.14% from the previous close of $952.31.
What is Precigen's market cap?
Precigen's market cap is $341.42B, based on a share price of $953.67 and 358M shares outstanding as of Jun 30, 2026.
How much revenue does Precigen make?
Precigen reported revenue of $9.68M for fiscal 2025, up 146.73% from fiscal 2024.
Does Precigen pay a dividend?
Precigen's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Precigen, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures